Jeanne Wei
Concepts (325)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Serum Response Factor | 11 | 2024 | 41 | 4.600 |
Why?
| Transcription Factors | 9 | 2024 | 622 | 2.840 |
Why?
| Myocardium | 13 | 2021 | 441 | 1.890 |
Why?
| Delirium | 2 | 2023 | 52 | 1.730 |
Why?
| Health Literacy | 2 | 2023 | 141 | 1.510 |
Why?
| Aging | 10 | 2016 | 784 | 1.490 |
Why?
| Actins | 3 | 2022 | 132 | 1.460 |
Why?
| Amino Acids, Essential | 3 | 2023 | 125 | 1.120 |
Why?
| MicroRNAs | 4 | 2016 | 386 | 1.100 |
Why?
| Accidental Falls | 3 | 2022 | 98 | 1.100 |
Why?
| Heart | 6 | 2016 | 360 | 1.070 |
Why?
| Gene Expression Regulation | 12 | 2016 | 1062 | 1.070 |
Why?
| Mice | 17 | 2024 | 6413 | 0.980 |
Why?
| Valine | 1 | 2024 | 54 | 0.940 |
Why?
| Amino Acids, Branched-Chain | 1 | 2024 | 44 | 0.910 |
Why?
| Glucose | 2 | 2017 | 366 | 0.880 |
Why?
| Heart Failure | 5 | 2019 | 541 | 0.810 |
Why?
| Physical Therapists | 1 | 2021 | 9 | 0.790 |
Why?
| Sirtuins | 1 | 2021 | 12 | 0.780 |
Why?
| Mitochondria | 6 | 2024 | 489 | 0.770 |
Why?
| Aged | 27 | 2023 | 10054 | 0.770 |
Why?
| Dietary Supplements | 3 | 2023 | 449 | 0.750 |
Why?
| Geriatrics | 4 | 2019 | 47 | 0.730 |
Why?
| Genetic Variation | 1 | 2021 | 253 | 0.700 |
Why?
| Primary Health Care | 2 | 2014 | 401 | 0.680 |
Why?
| Histones | 2 | 2022 | 335 | 0.660 |
Why?
| Animals | 19 | 2024 | 14385 | 0.640 |
Why?
| Sirtuin 2 | 1 | 2017 | 11 | 0.630 |
Why?
| RNA, Messenger | 7 | 2021 | 1202 | 0.630 |
Why?
| Doxorubicin | 5 | 2017 | 259 | 0.620 |
Why?
| Humans | 46 | 2024 | 54284 | 0.590 |
Why?
| Cytoskeletal Proteins | 1 | 2017 | 58 | 0.580 |
Why?
| Dementia | 2 | 2012 | 149 | 0.570 |
Why?
| Cell Line | 6 | 2024 | 1153 | 0.560 |
Why?
| Mitochondria, Heart | 1 | 2016 | 42 | 0.560 |
Why?
| Gastrostomy | 2 | 2014 | 60 | 0.550 |
Why?
| Oxidative Stress | 3 | 2024 | 958 | 0.540 |
Why?
| Alzheimer Disease | 3 | 2023 | 367 | 0.530 |
Why?
| Metformin | 1 | 2015 | 66 | 0.500 |
Why?
| Oxygen Consumption | 1 | 2015 | 223 | 0.490 |
Why?
| Alternative Splicing | 2 | 2021 | 64 | 0.490 |
Why?
| Hypoglycemic Agents | 1 | 2015 | 177 | 0.470 |
Why?
| Physicians, Primary Care | 1 | 2014 | 43 | 0.460 |
Why?
| beta-Galactosidase | 1 | 2013 | 42 | 0.460 |
Why?
| Hospitalization | 3 | 2018 | 705 | 0.440 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2013 | 84 | 0.440 |
Why?
| Blood Glucose | 1 | 2015 | 489 | 0.430 |
Why?
| Endoscopy, Gastrointestinal | 1 | 2012 | 75 | 0.430 |
Why?
| Antibiotics, Antineoplastic | 3 | 2017 | 85 | 0.420 |
Why?
| Health Services for the Aged | 1 | 2012 | 38 | 0.420 |
Why?
| Aged, 80 and over | 13 | 2021 | 3431 | 0.410 |
Why?
| Malnutrition | 1 | 2012 | 83 | 0.400 |
Why?
| Cardiomegaly | 1 | 2011 | 38 | 0.390 |
Why?
| Nitric Oxide | 1 | 2013 | 298 | 0.380 |
Why?
| Longevity | 2 | 2010 | 87 | 0.380 |
Why?
| Patient Discharge | 2 | 2013 | 353 | 0.380 |
Why?
| Quality Improvement | 2 | 2023 | 245 | 0.380 |
Why?
| Caregivers | 2 | 2023 | 241 | 0.370 |
Why?
| Gene Expression Profiling | 2 | 2012 | 1138 | 0.360 |
Why?
| Education, Medical, Graduate | 1 | 2012 | 225 | 0.350 |
Why?
| Chronic Disease | 1 | 2012 | 614 | 0.340 |
Why?
| Amino Acid Sequence | 5 | 2011 | 767 | 0.340 |
Why?
| Collagen | 1 | 2010 | 223 | 0.340 |
Why?
| Endocarditis, Bacterial | 1 | 2009 | 44 | 0.330 |
Why?
| Anabolic Agents | 2 | 2019 | 35 | 0.320 |
Why?
| NADH Dehydrogenase | 1 | 2008 | 17 | 0.320 |
Why?
| Electron Transport Complex I | 1 | 2008 | 42 | 0.310 |
Why?
| Mice, Transgenic | 4 | 2014 | 656 | 0.310 |
Why?
| Protein Structure, Tertiary | 2 | 2021 | 289 | 0.300 |
Why?
| Promoter Regions, Genetic | 4 | 2017 | 520 | 0.300 |
Why?
| Ventricular Pressure | 1 | 2006 | 19 | 0.300 |
Why?
| Insulin-Like Growth Factor I | 3 | 2016 | 137 | 0.290 |
Why?
| Isoproterenol | 1 | 2006 | 52 | 0.290 |
Why?
| Female | 24 | 2021 | 28441 | 0.290 |
Why?
| Trans-Activators | 3 | 2016 | 147 | 0.280 |
Why?
| Drug Therapy | 1 | 2006 | 50 | 0.280 |
Why?
| Nutritional Physiological Phenomena | 1 | 2006 | 22 | 0.280 |
Why?
| Cachexia | 1 | 2006 | 24 | 0.270 |
Why?
| Nuclear Proteins | 3 | 2016 | 252 | 0.270 |
Why?
| Protein Isoforms | 2 | 2021 | 124 | 0.260 |
Why?
| Residence Characteristics | 1 | 2006 | 166 | 0.260 |
Why?
| Self Care | 1 | 2006 | 147 | 0.260 |
Why?
| Cells, Cultured | 4 | 2015 | 1737 | 0.250 |
Why?
| Molecular Sequence Data | 4 | 2008 | 980 | 0.250 |
Why?
| Breast Neoplasms | 4 | 2017 | 1248 | 0.250 |
Why?
| Independent Living | 2 | 2021 | 46 | 0.250 |
Why?
| Human Umbilical Vein Endothelial Cells | 2 | 2016 | 95 | 0.250 |
Why?
| Lysine | 2 | 2022 | 102 | 0.240 |
Why?
| Cognition Disorders | 1 | 2006 | 240 | 0.240 |
Why?
| Isoleucine | 1 | 2024 | 25 | 0.240 |
Why?
| Male | 17 | 2021 | 27334 | 0.240 |
Why?
| Signal Transduction | 3 | 2024 | 1753 | 0.240 |
Why?
| Human Growth Hormone | 2 | 2017 | 51 | 0.230 |
Why?
| Leucine | 1 | 2024 | 113 | 0.230 |
Why?
| Lewy Body Disease | 1 | 2023 | 7 | 0.230 |
Why?
| Proteins | 1 | 2006 | 376 | 0.220 |
Why?
| Ternary Complex Factors | 1 | 2022 | 5 | 0.220 |
Why?
| Cell Size | 2 | 2014 | 45 | 0.220 |
Why?
| Anilides | 1 | 2022 | 18 | 0.220 |
Why?
| Estrogens, Conjugated (USP) | 1 | 2002 | 3 | 0.220 |
Why?
| Benzamides | 1 | 2022 | 54 | 0.220 |
Why?
| Blood Proteins | 1 | 2023 | 100 | 0.220 |
Why?
| Rats | 4 | 2017 | 3415 | 0.220 |
Why?
| NIH 3T3 Cells | 3 | 2008 | 55 | 0.210 |
Why?
| Mice, Inbred C57BL | 4 | 2016 | 1999 | 0.210 |
Why?
| Ambulatory Care Facilities | 1 | 2023 | 136 | 0.210 |
Why?
| Eating | 1 | 2023 | 155 | 0.210 |
Why?
| Base Sequence | 2 | 2017 | 719 | 0.210 |
Why?
| Cues | 1 | 2021 | 55 | 0.200 |
Why?
| Genome | 2 | 2021 | 74 | 0.200 |
Why?
| Adenosine Triphosphate | 1 | 2022 | 242 | 0.200 |
Why?
| Age Factors | 5 | 2010 | 1198 | 0.200 |
Why?
| Cardiovascular Diseases | 2 | 2021 | 476 | 0.190 |
Why?
| Up-Regulation | 2 | 2014 | 508 | 0.190 |
Why?
| Genetic Loci | 1 | 2021 | 58 | 0.190 |
Why?
| Exons | 1 | 2021 | 105 | 0.190 |
Why?
| Zinc | 1 | 2021 | 59 | 0.190 |
Why?
| Animals, Newborn | 2 | 2014 | 396 | 0.190 |
Why?
| Focus Groups | 1 | 2021 | 208 | 0.190 |
Why?
| United States | 5 | 2019 | 5217 | 0.170 |
Why?
| Ventricular Function, Left | 2 | 2017 | 181 | 0.170 |
Why?
| Food, Formulated | 1 | 2019 | 44 | 0.170 |
Why?
| Conserved Sequence | 2 | 2011 | 57 | 0.170 |
Why?
| Blood | 1 | 2017 | 30 | 0.160 |
Why?
| Culture Media | 1 | 2017 | 100 | 0.160 |
Why?
| Chemokines | 1 | 2017 | 96 | 0.150 |
Why?
| Transcriptome | 2 | 2017 | 346 | 0.150 |
Why?
| Tissue Distribution | 3 | 2008 | 178 | 0.150 |
Why?
| Stroke Volume | 1 | 2017 | 150 | 0.150 |
Why?
| Neocortex | 1 | 2016 | 8 | 0.150 |
Why?
| Cerebrovascular Disorders | 2 | 2018 | 53 | 0.150 |
Why?
| Down Syndrome | 1 | 2018 | 100 | 0.140 |
Why?
| Homeostasis | 1 | 2017 | 223 | 0.140 |
Why?
| Dietary Proteins | 1 | 2019 | 230 | 0.140 |
Why?
| Cell Culture Techniques | 1 | 2017 | 112 | 0.140 |
Why?
| Biomedical Research | 1 | 2019 | 240 | 0.140 |
Why?
| Comorbidity | 2 | 2012 | 663 | 0.140 |
Why?
| Transfection | 1 | 2017 | 399 | 0.140 |
Why?
| cdc42 GTP-Binding Protein | 1 | 2015 | 11 | 0.130 |
Why?
| AMP-Activated Protein Kinases | 1 | 2015 | 29 | 0.130 |
Why?
| Blotting, Western | 3 | 2006 | 683 | 0.130 |
Why?
| Aorta | 1 | 2016 | 177 | 0.130 |
Why?
| Prodromal Symptoms | 1 | 2014 | 12 | 0.130 |
Why?
| Enzyme Activation | 1 | 2015 | 329 | 0.130 |
Why?
| Protein Kinases | 1 | 2015 | 89 | 0.130 |
Why?
| Actin Cytoskeleton | 1 | 2014 | 26 | 0.130 |
Why?
| Gastroscopy | 1 | 2014 | 18 | 0.130 |
Why?
| Cell Death | 1 | 2015 | 223 | 0.130 |
Why?
| Double-Blind Method | 4 | 2021 | 742 | 0.130 |
Why?
| Transcription, Genetic | 2 | 2016 | 418 | 0.120 |
Why?
| Hippocampus | 1 | 2016 | 242 | 0.120 |
Why?
| Hospital Mortality | 3 | 2018 | 465 | 0.120 |
Why?
| Protein Binding | 2 | 2008 | 736 | 0.120 |
Why?
| Down-Regulation | 2 | 2016 | 388 | 0.120 |
Why?
| Coronary Disease | 1 | 2014 | 169 | 0.120 |
Why?
| Survival Analysis | 3 | 2013 | 735 | 0.110 |
Why?
| Retrospective Studies | 4 | 2018 | 6432 | 0.110 |
Why?
| Pneumonia, Aspiration | 1 | 2012 | 12 | 0.110 |
Why?
| Eukaryotic Initiation Factors | 1 | 2012 | 5 | 0.110 |
Why?
| Argonaute Proteins | 1 | 2012 | 11 | 0.110 |
Why?
| Models, Biological | 2 | 2008 | 823 | 0.110 |
Why?
| Multigene Family | 1 | 2012 | 54 | 0.110 |
Why?
| Enteral Nutrition | 1 | 2012 | 136 | 0.100 |
Why?
| Deglutition Disorders | 1 | 2012 | 71 | 0.100 |
Why?
| Adiponectin | 1 | 2012 | 76 | 0.100 |
Why?
| Cardiopulmonary Resuscitation | 1 | 2013 | 137 | 0.100 |
Why?
| Endoplasmic Reticulum | 1 | 2012 | 123 | 0.100 |
Why?
| Forecasting | 1 | 2012 | 161 | 0.100 |
Why?
| Gene Expression | 3 | 2016 | 664 | 0.100 |
Why?
| Adipocytes | 1 | 2012 | 129 | 0.100 |
Why?
| Length of Stay | 2 | 2018 | 683 | 0.100 |
Why?
| Hypertension | 1 | 2016 | 564 | 0.100 |
Why?
| Adult | 6 | 2017 | 14207 | 0.100 |
Why?
| Career Choice | 1 | 2012 | 116 | 0.100 |
Why?
| Algorithms | 1 | 2014 | 697 | 0.090 |
Why?
| Health Services Needs and Demand | 1 | 2012 | 190 | 0.090 |
Why?
| Mice, Inbred Strains | 1 | 2010 | 198 | 0.090 |
Why?
| Organ Size | 1 | 2010 | 237 | 0.090 |
Why?
| Diagnosis, Differential | 1 | 2014 | 1136 | 0.090 |
Why?
| Heart Diseases | 1 | 2012 | 237 | 0.090 |
Why?
| Cell Nucleus | 1 | 2010 | 203 | 0.090 |
Why?
| Extracorporeal Membrane Oxygenation | 1 | 2013 | 302 | 0.090 |
Why?
| Time Factors | 4 | 2014 | 3213 | 0.090 |
Why?
| Dose-Response Relationship, Drug | 1 | 2013 | 1476 | 0.090 |
Why?
| Longitudinal Studies | 2 | 2014 | 746 | 0.090 |
Why?
| Cardiovascular Agents | 1 | 2009 | 60 | 0.080 |
Why?
| Paclitaxel | 1 | 2009 | 103 | 0.080 |
Why?
| Cell Proliferation | 1 | 2013 | 1096 | 0.080 |
Why?
| Curriculum | 1 | 2012 | 429 | 0.080 |
Why?
| Cardiology | 1 | 2010 | 105 | 0.080 |
Why?
| Piperidines | 1 | 2009 | 103 | 0.080 |
Why?
| Drug-Eluting Stents | 1 | 2009 | 116 | 0.080 |
Why?
| NAD | 1 | 2008 | 46 | 0.080 |
Why?
| Pyrazoles | 1 | 2009 | 110 | 0.080 |
Why?
| Protein Subunits | 1 | 2008 | 85 | 0.080 |
Why?
| Serum Response Element | 1 | 2007 | 4 | 0.080 |
Why?
| Stereotyping | 1 | 2008 | 41 | 0.080 |
Why?
| Health Status | 2 | 2009 | 368 | 0.080 |
Why?
| Inflammation | 1 | 2012 | 674 | 0.080 |
Why?
| Codon, Nonsense | 1 | 2007 | 29 | 0.080 |
Why?
| Placebos | 2 | 2009 | 90 | 0.080 |
Why?
| Angioplasty, Balloon, Coronary | 1 | 2009 | 167 | 0.080 |
Why?
| HeLa Cells | 1 | 2008 | 291 | 0.070 |
Why?
| Reproducibility of Results | 2 | 2012 | 1304 | 0.070 |
Why?
| Myocytes, Cardiac | 1 | 2008 | 137 | 0.070 |
Why?
| Zinc Fingers | 1 | 2006 | 21 | 0.070 |
Why?
| Models, Genetic | 1 | 2007 | 209 | 0.070 |
Why?
| Sequence Alignment | 1 | 2006 | 146 | 0.070 |
Why?
| Logistic Models | 1 | 2009 | 995 | 0.070 |
Why?
| Organ Specificity | 1 | 2006 | 126 | 0.070 |
Why?
| Heart Rate | 1 | 2008 | 357 | 0.070 |
Why?
| Science | 1 | 2005 | 17 | 0.070 |
Why?
| Stress, Psychological | 1 | 2008 | 270 | 0.070 |
Why?
| Treatment Outcome | 4 | 2018 | 5604 | 0.070 |
Why?
| Middle Aged | 7 | 2017 | 13088 | 0.070 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 673 | 0.060 |
Why?
| Binding Sites | 1 | 2006 | 440 | 0.060 |
Why?
| Two-Hybrid System Techniques | 1 | 2004 | 26 | 0.060 |
Why?
| Atrial Natriuretic Factor | 1 | 2004 | 24 | 0.060 |
Why?
| Blotting, Northern | 1 | 2004 | 108 | 0.060 |
Why?
| Blood Pressure | 1 | 2008 | 587 | 0.060 |
Why?
| Coronary Artery Disease | 1 | 2009 | 329 | 0.060 |
Why?
| Immunoprecipitation | 1 | 2004 | 73 | 0.060 |
Why?
| Patient Compliance | 1 | 2006 | 249 | 0.060 |
Why?
| DNA, Complementary | 1 | 2004 | 145 | 0.060 |
Why?
| Sequence Homology, Amino Acid | 1 | 2004 | 180 | 0.060 |
Why?
| Proportional Hazards Models | 3 | 2014 | 431 | 0.060 |
Why?
| Transcriptional Activation | 1 | 2004 | 134 | 0.060 |
Why?
| Homeodomain Proteins | 1 | 2004 | 82 | 0.060 |
Why?
| Leukocytes, Mononuclear | 2 | 2016 | 133 | 0.060 |
Why?
| Plasmids | 1 | 2004 | 180 | 0.060 |
Why?
| Glutathione Transferase | 1 | 2004 | 178 | 0.060 |
Why?
| Microscopy, Fluorescence | 1 | 2004 | 198 | 0.060 |
Why?
| Antineoplastic Agents | 1 | 2012 | 1300 | 0.060 |
Why?
| Echocardiography, Doppler | 1 | 2003 | 61 | 0.060 |
Why?
| Cardiomyopathies | 1 | 2004 | 129 | 0.060 |
Why?
| Tomography, Emission-Computed, Single-Photon | 1 | 2023 | 57 | 0.060 |
Why?
| Models, Animal | 1 | 2003 | 255 | 0.050 |
Why?
| Ventricular Dysfunction, Left | 1 | 2003 | 98 | 0.050 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 158 | 0.050 |
Why?
| Aggression | 1 | 2002 | 60 | 0.050 |
Why?
| Dopamine | 1 | 2023 | 190 | 0.050 |
Why?
| Point Mutation | 1 | 2002 | 92 | 0.050 |
Why?
| Drug Administration Schedule | 1 | 2002 | 401 | 0.050 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2003 | 164 | 0.050 |
Why?
| Risk Factors | 3 | 2018 | 3935 | 0.050 |
Why?
| Psychiatric Status Rating Scales | 1 | 2002 | 346 | 0.050 |
Why?
| Positron-Emission Tomography | 1 | 2023 | 322 | 0.050 |
Why?
| Disease Models, Animal | 1 | 2006 | 1639 | 0.050 |
Why?
| Cross-Sectional Studies | 1 | 2006 | 1693 | 0.050 |
Why?
| Geriatric Assessment | 1 | 2021 | 126 | 0.050 |
Why?
| DNA, Mitochondrial | 1 | 2002 | 186 | 0.050 |
Why?
| Qualitative Research | 1 | 2021 | 331 | 0.050 |
Why?
| National Institute on Aging (U.S.) | 1 | 2019 | 2 | 0.040 |
Why?
| Europe | 1 | 2019 | 102 | 0.040 |
Why?
| Beverages | 1 | 2019 | 83 | 0.040 |
Why?
| Meals | 1 | 2019 | 62 | 0.040 |
Why?
| Severity of Illness Index | 1 | 2002 | 1084 | 0.040 |
Why?
| Registries | 2 | 2013 | 553 | 0.040 |
Why?
| Myocardial Infarction | 2 | 2014 | 427 | 0.040 |
Why?
| Matrix Metalloproteinases | 1 | 2017 | 52 | 0.040 |
Why?
| Lung Neoplasms | 1 | 2003 | 642 | 0.040 |
Why?
| Blood-Brain Barrier | 1 | 2016 | 59 | 0.040 |
Why?
| Polymorphism, Genetic | 1 | 2017 | 193 | 0.030 |
Why?
| Gene Regulatory Networks | 1 | 2017 | 124 | 0.030 |
Why?
| Arginine | 1 | 2017 | 182 | 0.030 |
Why?
| Angiotensin II | 1 | 2016 | 166 | 0.030 |
Why?
| Myocardial Revascularization | 1 | 2014 | 18 | 0.030 |
Why?
| Analysis of Variance | 1 | 2016 | 635 | 0.030 |
Why?
| Pilot Projects | 1 | 2017 | 808 | 0.030 |
Why?
| Intubation, Gastrointestinal | 1 | 2014 | 27 | 0.030 |
Why?
| Mice, Knockout | 1 | 2016 | 926 | 0.030 |
Why?
| Health Surveys | 1 | 2014 | 263 | 0.030 |
Why?
| Acute Disease | 1 | 2014 | 403 | 0.030 |
Why?
| Cohort Studies | 1 | 2018 | 1543 | 0.030 |
Why?
| Molecular Sequence Annotation | 1 | 2012 | 31 | 0.030 |
Why?
| Lymphopenia | 1 | 2012 | 21 | 0.030 |
Why?
| Thapsigargin | 1 | 2012 | 10 | 0.030 |
Why?
| Tunicamycin | 1 | 2012 | 17 | 0.030 |
Why?
| Palmitic Acid | 1 | 2012 | 25 | 0.030 |
Why?
| Socioeconomic Factors | 1 | 2014 | 642 | 0.030 |
Why?
| Sex Factors | 1 | 2014 | 767 | 0.030 |
Why?
| Thrombocytopenia | 1 | 2012 | 99 | 0.030 |
Why?
| Cognition | 1 | 2014 | 348 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2014 | 1048 | 0.030 |
Why?
| Stents | 1 | 2014 | 375 | 0.020 |
Why?
| RNA | 1 | 2012 | 202 | 0.020 |
Why?
| Stem Cells | 1 | 2012 | 193 | 0.020 |
Why?
| Survival Rate | 1 | 2013 | 951 | 0.020 |
Why?
| Phosphorylation | 1 | 2012 | 614 | 0.020 |
Why?
| Brazil | 1 | 2010 | 35 | 0.020 |
Why?
| Liver | 1 | 2016 | 1225 | 0.020 |
Why?
| Multicenter Studies as Topic | 1 | 2009 | 91 | 0.020 |
Why?
| Body Mass Index | 1 | 2012 | 713 | 0.020 |
Why?
| Safety | 1 | 2009 | 92 | 0.020 |
Why?
| Perceptual Masking | 1 | 2008 | 12 | 0.020 |
Why?
| Vocabulary | 1 | 2008 | 18 | 0.020 |
Why?
| Evidence-Based Medicine | 1 | 2009 | 281 | 0.020 |
Why?
| Kaplan-Meier Estimate | 1 | 2009 | 514 | 0.020 |
Why?
| Administration, Oral | 1 | 2009 | 459 | 0.020 |
Why?
| Patient Selection | 1 | 2009 | 286 | 0.020 |
Why?
| Attitude | 1 | 2008 | 82 | 0.020 |
Why?
| Young Adult | 1 | 2016 | 4318 | 0.020 |
Why?
| Body Composition | 1 | 2009 | 349 | 0.020 |
Why?
| Thrombosis | 1 | 2009 | 243 | 0.020 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2009 | 596 | 0.020 |
Why?
| Genetic Engineering | 1 | 2005 | 27 | 0.020 |
Why?
| Research | 1 | 2005 | 110 | 0.020 |
Why?
| Adolescent | 1 | 2016 | 6897 | 0.020 |
Why?
| Health Policy | 1 | 2005 | 171 | 0.020 |
Why?
| Risk Assessment | 1 | 2009 | 1361 | 0.020 |
Why?
| Cheek | 1 | 2002 | 9 | 0.010 |
Why?
| Mouth Mucosa | 1 | 2002 | 31 | 0.010 |
Why?
| Mitosis | 1 | 2002 | 106 | 0.010 |
Why?
| Cell Division | 1 | 2002 | 330 | 0.010 |
Why?
| Sequence Analysis, DNA | 1 | 2002 | 273 | 0.010 |
Why?
| Gene Deletion | 1 | 2002 | 293 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 2002 | 531 | 0.010 |
Why?
| Epithelial Cells | 1 | 2002 | 255 | 0.010 |
Why?
| Prognosis | 1 | 2003 | 2118 | 0.010 |
Why?
| Mutation | 1 | 2002 | 1501 | 0.010 |
Why?
| Infant | 1 | 2002 | 3817 | 0.010 |
Why?
| Child, Preschool | 1 | 2002 | 4147 | 0.010 |
Why?
| Neoplasms | 1 | 2002 | 1316 | 0.010 |
Why?
| Child | 1 | 2002 | 7341 | 0.010 |
Why?
|
|
Wei's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|